These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19475756)

  • 1. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study.
    Alonso A; Logroscino G; Jick SS; Hernán MA
    Eur J Neurol; 2009 Jun; 16(6):745-51. PubMed ID: 19475756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of and risk factors for motor neurone disease in UK women: a prospective study.
    Doyle P; Brown A; Beral V; Reeves G; Green J
    BMC Neurol; 2012 May; 12():25. PubMed ID: 22559076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor neuron disease mortality rates in New Zealand 1992-2013.
    Cao MC; Chancellor A; Charleston A; Dragunow M; Scotter EL
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):285-293. PubMed ID: 29382218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nationwide incidence of motor neuron disease using the French health insurance information system database.
    Kab S; Moisan F; Preux PM; Marin B; Elbaz A
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Aug; 18(5-6):426-433. PubMed ID: 28387141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of motor neurone disease in two counties in the southwest of England.
    Imam I; Ball S; Wright D; Hanemann CO; Zajicek J
    J Neurol; 2010 Jun; 257(6):977-81. PubMed ID: 20094727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of amyotrophic lateral sclerosis and other motor neuron disease among men with benign prostatic hyperplasia: a population-based cohort study.
    Sørensen TT; Horváth-Puhó E; Nørgaard M; Ehrenstein V; Henderson VW
    BMJ Open; 2019 Jul; 9(7):e030015. PubMed ID: 31278107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An all-Ireland epidemiological study of MND, 2004-2005.
    Donaghy C; O'Toole O; Sheehan C; Kee F; Hardiman O; Patterson V
    Eur J Neurol; 2009 Jan; 16(1):148-53. PubMed ID: 19087159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the incidence of motor neuron disease higher in French military personnel?
    Vlaar T; Elbaz A; Moisan F
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):107-115. PubMed ID: 31621421
    [No Abstract]   [Full Text] [Related]  

  • 9. British motor neuron disease twin study.
    Graham AJ; Macdonald AM; Hawkes CH
    J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):562-9. PubMed ID: 9219739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographical epidemiology of residence of patients with motor neuron disease in Lancashire and south Cumbria.
    Mitchell JD; Gatrell AC; Al-Hamad A; Davies RB; Batterby G
    J Neurol Neurosurg Psychiatry; 1998 Dec; 65(6):842-7. PubMed ID: 9854959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-dependent sex ratios of motor neuron disease: French nationwide study and meta-analysis.
    Ahmadzai P; Kab S; Vlaar T; Artaud F; Carcaillon-Bentata L; Canonico M; Moisan F; Elbaz A
    Neurology; 2018 May; 90(18):e1588-e1595. PubMed ID: 29602909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and medical expenses of motor neuron diseases in Taiwan.
    Lai CH; Tseng HF
    Neuroepidemiology; 2008; 31(3):159-66. PubMed ID: 18784414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiological study of motor neuron disease in Hokkaido island--its incidence, prevalence and regional distributions--ALS Study Group].
    Okumura H; Moriwaka F; Tashiro K; Hamada T; Matsumoto A; Matsumoto H; Itoh N; Shindo R; Takahata N
    No To Shinkei; 1992 Aug; 44(8):727-32. PubMed ID: 1419350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Scottish morbidity and mortality data for epidemiological studies of motor neuron disease.
    Chancellor AM; Swingler RJ; Fraser H; Clarke JA; Warlow CP
    J Epidemiol Community Health; 1993 Apr; 47(2):116-20. PubMed ID: 8326268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing mortality for motor neuron disease in France (1968-2007): an age-period-cohort analysis.
    Gordon PH; Artaud F; Aouba A; Laurent F; Meininger V; Elbaz A
    Eur J Epidemiol; 2011 Sep; 26(9):729-37. PubMed ID: 21674216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of incidence of motor neuron disease in England 1998-2019: use of three linked datasets.
    Burchardt JM; Mei XW; Ranger T; McDermott CJ; Radunovic A; Coupland C; Hippisley-Cox J
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug; 23(5-6):363-371. PubMed ID: 35103515
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort.
    Alonso A; Jick SS; Olek MJ; Hernán MA
    J Neurol; 2007 Dec; 254(12):1736-41. PubMed ID: 17896096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An epidemic-like cluster of motor neuron disease in a Swedish county during the period 1973-1984.
    Gunnarsson LG; Lygner PE; Veiga-Cabo J; de Pedro-Cuesta J
    Neuroepidemiology; 1996; 15(3):142-52. PubMed ID: 8700306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing epidemiology of motor neurone disease in Scotland.
    Leighton DJ; Newton J; Stephenson LJ; Colville S; Davenport R; Gorrie G; Morrison I; Swingler R; Chandran S; Pal S;
    J Neurol; 2019 Apr; 266(4):817-825. PubMed ID: 30805795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.
    Conde B; Winck JC; Azevedo LF
    Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.